These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6981047)

  • 1. Regulatory factors of lymphocyte-lymphocyte interaction. II. Characterization of human mitogenic factor derived from the culture supernatant of a mouse-human hybridoma.
    Kawano M; Namba Y; Hanaoka M
    Microbiol Immunol; 1982; 26(3):253-69. PubMed ID: 6981047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory factors of lymphocyte-lymphocyte interaction. I. Con A-induced mitogenic factor acts on the late G1 stage of T-cell proliferation.
    Kawano M; Namba Y; Hanaoka M
    Microbiol Immunol; 1981; 25(5):505-15. PubMed ID: 6974296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial purification and characterization of B cell growth factor constitutively secreted by human T-cell hybridoma.
    Pathak SK; Tsang KY; Cathcart MK; Arnaud P; Boutin B; Fudenberg HH
    Immunol Lett; 1985; 10(6):339-46. PubMed ID: 3930398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of guinea pig mitogenic factors. I. Evidence that antigen-induced mitogenic factor and mitogenic factor from mixed leukocyte cultures are distinct molecular entities.
    Geczy CL
    J Immunol; 1977 Dec; 119(6):2107-13. PubMed ID: 144166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mitogenic factor, released by stimulated human mononuclear cells and distinct from interleukin 2 (IL 2), B cell growth factor (BCGF), and interleukin 1 (IL 1).
    Kasakura S; Taguchi M; Watanabe Y; Okubo T; Murachi T; Uchino H; Hanaoka M
    J Immunol; 1984 Dec; 133(6):3084-90. PubMed ID: 6238094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a human mitogenic factor (MF) released by phytohemagglutinin-activated lymphocytes.
    Larsson EL; Mannervik B; Blomgren H
    Cell Immunol; 1979 May; 44(2):424-32. PubMed ID: 313270
    [No Abstract]   [Full Text] [Related]  

  • 7. Constitutive and mitogen-induced production of T cell growth factor by stable T cell hybridoma lines.
    Altman A; Sferruzza A; Weiner RG; Katz DH
    J Immunol; 1982 Mar; 128(3):1365-71. PubMed ID: 6120196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of monoclonal B cell growth factor (BCGF) produced by a human T-T hybridoma.
    Butler JL; Ambrus JL; Fauci AS
    J Immunol; 1984 Jul; 133(1):251-5. PubMed ID: 6427336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A human T-T-cell hybridoma-derived lymphocyte chemoattractant factor.
    Theodore AC; Center DM; Cruikshank WW; Beer DJ
    Cell Immunol; 1986 Apr; 98(2):411-21. PubMed ID: 3093096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a T cell hybridoma that produces large quantities of macrophage-activating factor.
    Schreiber RD; Altman A; Katz DH
    J Exp Med; 1982 Sep; 156(3):677-89. PubMed ID: 7050288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification and biochemical characterization of human lymphocyte mitogenic factor (LMF).
    Rutenberg WD; al-Khalidi U; Rosen FS; Merler E
    J Immunol; 1979 Feb; 122(2):723-7. PubMed ID: 310850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycosylation-inhibiting factor from human T cell hybridomas constructed from peripheral blood lymphocytes of a bee venom-sensitive allergic patient.
    Thomas P; Gomi H; Takeuchi T; Carini C; Tagaya Y; Ishizaka K
    J Immunol; 1992 Feb; 148(3):729-37. PubMed ID: 1730869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BCGFII activity on activated B cells of a purified murine T cell-replacing factor (TRF) from a T cell hybridoma (B151K12).
    Harada N; Kikuchi Y; Tominaga A; Takaki S; Takatsu K
    J Immunol; 1985 Jun; 134(6):3944-51. PubMed ID: 3872907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Physicochemical properties of the human lymphocyte mitogenic factor induced by phytohemagglutinin].
    Voĭtenok NN; Varivotskaia NV; Murzenok PP; Potemkina ND
    Biull Eksp Biol Med; 1976 Aug; 82(8):963-5. PubMed ID: 1026298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of human monocyte cytotoxicity by natural and recombinant immune interferon.
    Le J; Prensky W; Yip YK; Chang Z; Hoffman T; Stevenson HC; Balazs I; Sadlik JR; Vilcek J
    J Immunol; 1983 Dec; 131(6):2821-6. PubMed ID: 6417232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dendritic cell activating factor produced by mouse macrophage hybridoma.
    Ito A; Woo HJ; Imai Y; Osawa T
    Microbiol Immunol; 1988; 32(10):1059-72. PubMed ID: 3231128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human cell lines secreting lymphokines. I. Establishment of T-T hybridomas.
    Epstein N; Gozes Y; Halmann M; Kobiler D
    Dev Biol Stand; 1987; 66():439-46. PubMed ID: 3108054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physicochemical characterization of chemotatic lymphokines produced by human T and B lymphocytes.
    Altman LC; Chassy B; Mackler BF
    J Immunol; 1975 Jul; 115(1):18-21. PubMed ID: 1097502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of cytotoxic T lymphocytes from thymocyte precursors to trinitrophenyl-modified self antigens. II. Establishment of a T cell hybrid clone constitutively producing killer-helper factor(s) (KHF) and functional analysis of released KHF.
    Kikuchi Y; Kato R; Sano Y; Takahashi H; Kanatani T; Takatsu K
    J Immunol; 1986 May; 136(10):3553-60. PubMed ID: 2939132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A T-helper cell x Molt4 human hybridoma constitutively producing B-cell stimulatory and inhibitory factors.
    Rosén A; Uggla C; Szigeti R; Kallin B; Lindqvist C; Zeuthen J
    Lymphokine Res; 1986; 5(3):185-204. PubMed ID: 2943947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.